|
US4849224A
(en)
*
|
1987-11-12 |
1989-07-18 |
Theratech Inc. |
Device for administering an active agent to the skin or mucosa
|
|
JPH02149514A
(ja)
*
|
1988-04-06 |
1990-06-08 |
Nitto Denko Corp |
医薬部材
|
|
DE69108136T2
(de)
*
|
1990-08-03 |
1995-11-02 |
Terumo Corp |
Wundabdeckmaterial.
|
|
GB9021674D0
(en)
*
|
1990-10-05 |
1990-11-21 |
Ethical Pharma Ltd |
Transdermal device
|
|
US5240917A
(en)
*
|
1991-04-03 |
1993-08-31 |
Keimowitz Rudolph M |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
|
US5123900A
(en)
*
|
1991-08-16 |
1992-06-23 |
Bertek, Inc. |
Moisture permeable double disk
|
|
CH686816A5
(de)
*
|
1992-02-04 |
1996-07-15 |
Asulab Ag |
Einrichtung zur Abgabe eines Arzneimittels.
|
|
US6071896A
(en)
*
|
1992-06-16 |
2000-06-06 |
Gundersen Clinic, Ltd. |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
|
DE9219105U1
(de)
*
|
1992-10-31 |
1998-03-05 |
Klocke Verpackungs-Service GmbH, 76356 Weingarten |
Behälter zur Aufnahme von aromatischen Substanzen
|
|
ES2199954T3
(es)
*
|
1992-11-09 |
2004-03-01 |
Neurogesx, Inc. |
Administracion transdermica de cetorolac.
|
|
FR2709670B1
(fr)
*
|
1993-09-10 |
1995-10-20 |
Asulab Sa |
Dispositif en trois modules pour l'administration transdermique de médicaments par électrophorèse ou iontophorèse.
|
|
CN1131018C
(zh)
*
|
1994-03-07 |
2003-12-17 |
瑟拉技术有限公司 |
含药物的粘着复合的透皮给药药贴及其制备方法
|
|
DE4423850A1
(de)
*
|
1994-07-07 |
1996-01-11 |
Labtec Gmbh |
Transdermales therapeutisches System zur Applikation von Naloxon
|
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
|
US5730721A
(en)
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
|
US6248789B1
(en)
|
1996-08-29 |
2001-06-19 |
Stuart L. Weg |
Administration of ketamine to manage pain and to reduce drug dependency
|
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
|
US6119036A
(en)
*
|
1997-03-26 |
2000-09-12 |
The Board Of Regents Of The University Of Oklahoma |
Iontophoretic transdermal delivery device
|
|
US5919476A
(en)
*
|
1997-09-29 |
1999-07-06 |
Pmt Corporation |
Reinforced gel sheeting for scar treatment
|
|
DE19743484C1
(de)
*
|
1997-10-01 |
1999-01-28 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
|
|
US7011843B2
(en)
|
1997-10-01 |
2006-03-14 |
Lts Lohmann-Therapie Systeme Ag |
Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
|
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
|
US6087341A
(en)
*
|
1998-02-12 |
2000-07-11 |
The Board Of Trustees Of The Leland Standford Junior University |
Introduction of nucleic acid into skin cells by topical application
|
|
ES2226394T3
(es)
*
|
1998-05-22 |
2005-03-16 |
Novosis Ag |
Sistemas transdermales que contienen substancia activa que se libera de forma controlada en el tiempo.
|
|
DE19929197A1
(de)
*
|
1999-06-25 |
2000-12-28 |
Novosis Pharma Ag |
Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung
|
|
DE19934523A1
(de)
*
|
1999-07-22 |
2001-01-25 |
Novosis Pharma Ag |
Transdermalsysteme zur Abgabe von Muscarin-Rezeptor-Antagonisten und ihre Verwendung zur Behandlung von Spasmen der glatten Muskulatur im urologischen Bereich
|
|
US7713546B1
(en)
|
2001-04-03 |
2010-05-11 |
Soft Gel Technologies, Inc. |
Corosolic acid formulation and its application for weight-loss management and blood sugar balance
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
|
AU2002316053A1
(en)
|
2001-05-01 |
2002-11-11 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
CA2445086C
(en)
|
2001-05-01 |
2008-04-08 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
EP1546184A4
(en)
*
|
2002-07-16 |
2006-08-23 |
Univ South Florida |
HUMAN IMMUNOSUPPRESSIVE PROTEIN
|
|
SI1534286T1
(sl)
|
2002-07-29 |
2010-04-30 |
Rigel Pharmaceuticals Inc |
Postopki za zdravljenje ali prepreŽŤevanje avtoimunskih bolezni z 2,4-pirimidindiaminskimi spojinami
|
|
NZ540282A
(en)
|
2002-11-18 |
2008-06-30 |
Yaupon Therapeutics Inc |
Analgesic uses of norketamine and ketamine/norketamine prodrugs
|
|
CA2729967C
(en)
*
|
2002-12-13 |
2018-01-16 |
Schering-Plough Healthcare Products, Inc. |
Use of a transdermal or transmucosal ingredient delivery device
|
|
WO2004094457A2
(en)
*
|
2003-04-16 |
2004-11-04 |
Arizona Board Of Regents, Acting For And On Behalf Of, Arizona State University |
Stable rgd peptidomimetic composition
|
|
WO2004093788A2
(en)
*
|
2003-04-17 |
2004-11-04 |
The Trustees Of Columbia University In The City Ofnew York |
Desmoglein 4 is a novel gene involved in hair growth
|
|
WO2005007020A2
(en)
|
2003-07-03 |
2005-01-27 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
|
CA2537488A1
(en)
*
|
2003-09-08 |
2005-03-17 |
Pfizer Health Ab |
Nicotine formulations and use thereof
|
|
AU2005210637B2
(en)
|
2004-01-30 |
2010-09-16 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Rapidly dissolving film for delivery of an active agent
|
|
US20050186269A1
(en)
*
|
2004-02-25 |
2005-08-25 |
Udell Ronald G. |
Stabilized feverfew formulations
|
|
AU2005238034A1
(en)
|
2004-04-23 |
2005-11-10 |
The Trustees Of Columbia University In The City Of New York |
Inhibition of hairless protein mRNA
|
|
US20050249791A1
(en)
*
|
2004-05-07 |
2005-11-10 |
3M Innovative Properties Company |
Antimicrobial articles
|
|
GB2414461B
(en)
*
|
2004-05-24 |
2007-09-12 |
Mark Rupert Tucker |
Form-fill-seal process
|
|
CA2576158C
(en)
|
2004-08-05 |
2020-10-27 |
Corium International, Inc. |
Adhesive composition
|
|
US20060051435A1
(en)
*
|
2004-08-19 |
2006-03-09 |
Udell Ronald G |
Nutritional supplement for body fat reduction
|
|
US20060079513A1
(en)
*
|
2004-10-13 |
2006-04-13 |
Preston David M |
Methods and compositions including methscopolamine nitrate
|
|
US20060079514A1
(en)
*
|
2004-10-13 |
2006-04-13 |
Victory Pharma Incorporated |
Methods and compositions including methscopolamine bromide
|
|
US8252320B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
|
ES2346895T3
(es)
|
2004-10-21 |
2010-10-21 |
Durect Corporation |
Sistemas de administracion transdermica.
|
|
GB2421431B
(en)
*
|
2004-12-24 |
2007-10-10 |
Aquasol Ltd |
Dosing systems
|
|
US20070104805A1
(en)
*
|
2005-11-01 |
2007-05-10 |
Udell Ronald G |
Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
|
|
AT502717A1
(de)
*
|
2005-11-09 |
2007-05-15 |
Omnica Gmbh |
Pharmazeutische verwendung einer verbindung
|
|
GB0523031D0
(en)
*
|
2005-11-11 |
2005-12-21 |
Yaupon Therapeutics |
Enhancement of morphine analgesia by s(-)-norketamine
|
|
EP1965777A1
(en)
*
|
2005-12-08 |
2008-09-10 |
Fertin Pharma |
Transdermal tobacco alkaloid patch
|
|
EP1965776A1
(en)
*
|
2005-12-08 |
2008-09-10 |
Fertin Pharma |
Low flexural strength transdermal tobacco alkaloid patch
|
|
EP1991532B1
(en)
|
2006-02-24 |
2017-01-11 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
EP2007877B1
(en)
|
2006-02-28 |
2013-04-17 |
The Trustees of Columbia University in the City of New York |
Methods for compact aggregation of dermal cells
|
|
AT503329A1
(de)
*
|
2006-03-02 |
2007-09-15 |
Omnica Gmbh |
Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält
|
|
AT503521A1
(de)
*
|
2006-05-05 |
2007-11-15 |
Omnica Gmbh |
Verwendung eines extraktes von kiwi-frucht
|
|
US8278358B2
(en)
*
|
2006-07-06 |
2012-10-02 |
Omnica Gmbh |
Lipoic acid derivatives
|
|
RS54764B1
(sr)
|
2006-07-21 |
2016-10-31 |
Biodelivery Sciences Int Inc |
Sredstvo za transmukozalnu isporuku sa povećanim nakupljanjem
|
|
JP2008044926A
(ja)
*
|
2006-08-14 |
2008-02-28 |
Trustees Of Columbia Univ In The City Of New York |
Ｗｎｔ信号伝達に関係した分泌タンパク質
|
|
US8193197B2
(en)
|
2006-10-19 |
2012-06-05 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
EP2420505A1
(en)
|
2006-11-21 |
2012-02-22 |
Rigel Pharmaceuticals, Inc. |
Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
|
|
US7820207B2
(en)
*
|
2007-03-15 |
2010-10-26 |
Omnica Gmbh |
Stabilized anthocyanin compositions
|
|
US8623429B2
(en)
|
2007-03-15 |
2014-01-07 |
Omnica Gmbh |
Stabilized anthocyanin compositions
|
|
US20080293644A1
(en)
*
|
2007-04-27 |
2008-11-27 |
Thomas Eidenberger |
Guava extract
|
|
AU2007353989A1
(en)
*
|
2007-05-31 |
2008-12-04 |
Fertin Pharma A/S |
Transdermal tobacco alkaloid reservoir patch
|
|
US8034983B2
(en)
*
|
2007-06-06 |
2011-10-11 |
Multi-Tech Specialty Chemicals, Co., Ltd. |
Process for the preparation of xanthophyll crystals
|
|
DK2176208T3
(en)
|
2007-07-30 |
2015-04-27 |
Zynerba Pharmaceuticals Inc |
Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
|
|
US20110015158A1
(en)
|
2007-12-11 |
2011-01-20 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
WO2009089380A2
(en)
*
|
2008-01-08 |
2009-07-16 |
The Trustees Of Columbia University In The City Of New York |
Methods for p2ry5 mediated regulation of hair growth and mutants thereof
|
|
US20090247619A1
(en)
*
|
2008-03-06 |
2009-10-01 |
University Of Kentucky |
Cannabinoid-Containing Compositions and Methods for Their Use
|
|
WO2009131951A2
(en)
*
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising isoxazole derivatives
|
|
US20090270398A1
(en)
*
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, Compositions and Methods Comprising Pyridazine Derivatives
|
|
WO2009131957A2
(en)
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising oxadiazole derivatives
|
|
WO2009131958A2
(en)
*
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising triazine derivatives
|
|
HUE026331T2
(en)
*
|
2008-08-22 |
2016-06-28 |
Sanofi Sa |
[4- (5-Aminomethyl-2-fluoro-phenyl) -piperidin-1-yl] - [7-fluoro-1- (2-methoxy-ethyl) -4-trifluoromethoxy-1H-indol-3-ylmethanone as mast cell tryptase inhibitor
|
|
US20110237528A1
(en)
*
|
2008-09-19 |
2011-09-29 |
Institute For Oneworld Health |
Compositions and methods comprising imidazole and triazole derivatives
|
|
AR074776A1
(es)
|
2008-12-18 |
2011-02-09 |
Sanofi Aventis |
Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
|
|
EP2382210B1
(en)
|
2008-12-30 |
2017-03-01 |
Rigel Pharmaceuticals, Inc. |
Pyrimidinediamine kinase inhibitors
|
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
HUE026315T2
(en)
|
2009-01-23 |
2016-06-28 |
Rigel Pharmaceuticals Inc |
Preparations and methods for inhibiting the JAK pathway
|
|
CN104523661A
(zh)
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
US8511216B2
(en)
*
|
2009-03-30 |
2013-08-20 |
Kanzaki Kokyukoki Mfg. Co., Ltd. |
Hydraulic actuator unit
|
|
US8343976B2
(en)
*
|
2009-04-20 |
2013-01-01 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising pyrazole derivatives
|
|
KR101722289B1
(ko)
|
2009-07-08 |
2017-03-31 |
데르미라 (캐나다), 인코포레이티드 |
피부과 질환 또는 증상의 치료에 유용한 ｔｏｆａ 유사체
|
|
US20110034415A1
(en)
|
2009-07-20 |
2011-02-10 |
Thomas Eidenberger |
Walnut extracts for nutraceutical applications
|
|
WO2011022371A2
(en)
*
|
2009-08-17 |
2011-02-24 |
Silipos Inc. |
Gel product
|
|
FR2955324A1
(fr)
|
2010-01-15 |
2011-07-22 |
Sanofi Aventis |
[4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones disubstituees
|
|
US20110144200A1
(en)
|
2009-12-14 |
2011-06-16 |
Thomas Eidenberger |
Combination of carotenoids and epi-lutein
|
|
ES2481790T3
(es)
|
2009-12-23 |
2014-07-31 |
Sanofi |
Profármacos de [4[4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(1H-pirrolo-piridin-il)-metanonas y síntesis de los mismos
|
|
RU2012131280A
(ru)
|
2009-12-23 |
2014-02-10 |
Санофи |
[4-(5-аминометил-2-фторфенил)пиперидин-1-ил]-(1н-пирролопиридинил)метаноны и их синтез
|
|
WO2011130716A2
(en)
|
2010-04-16 |
2011-10-20 |
Access Pharmaceuticals, Inc. |
A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
|
|
CN103068390A
(zh)
|
2010-04-20 |
2013-04-24 |
寰宇一家健康研究所 |
包含哒嗪磺酰胺衍生物的化合物、组合物和方法
|
|
US20110288103A1
(en)
|
2010-04-20 |
2011-11-24 |
Institute For Oneworld Health |
Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives
|
|
KR101379370B1
(ko)
|
2010-04-24 |
2014-03-28 |
비아멧 파마슈티컬즈, 인코포레이티드 |
금속효소 억제제 화합물
|
|
US20120208855A1
(en)
|
2010-07-12 |
2012-08-16 |
Sanofi |
Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
|
|
DK2598500T3
(da)
|
2010-07-28 |
2021-07-26 |
Rigel Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til hæmning af jak-reaktionsvejen
|
|
CA2816088A1
(en)
|
2010-10-28 |
2012-05-03 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
KR102027394B1
(ko)
|
2010-11-02 |
2019-10-01 |
더 트러스티스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 |
탈모 질환의 치료 방법
|
|
WO2012064943A2
(en)
|
2010-11-13 |
2012-05-18 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
BR112013014484A2
(pt)
|
2010-12-13 |
2016-07-19 |
Viamet Pharmaceuticals Inc |
compostos inibidores de metaloenzimas
|
|
AU2010365803B2
(en)
|
2010-12-20 |
2015-02-05 |
Colgate-Palmolive Company |
Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
|
|
WO2012116254A2
(en)
|
2011-02-25 |
2012-08-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chrysophaentin analogs that inhibit ftsz protein
|
|
EP2683410A2
(en)
|
2011-03-08 |
2014-01-15 |
Access Pharmaceuticals, Inc. |
Targeted nanocarrier systems for delivery of actives across biological membranes
|
|
JP6247632B2
(ja)
|
2011-06-19 |
2017-12-13 |
ヴィアメット ファーマスーティカルズ，インコーポレイテッド |
メタロ酵素阻害剤化合物
|
|
BR102012015199A2
(pt)
|
2011-06-19 |
2014-05-13 |
Viamet Pharmaceuticals Inc |
Compostos inibidores de metaloenzima
|
|
CN109400594A
(zh)
|
2011-06-23 |
2019-03-01 |
威尔金制药(Nc)有限公司 |
金属酶抑制剂化合物
|
|
WO2013019169A1
(en)
|
2011-08-01 |
2013-02-07 |
Institute For Oneworld Health |
Phosphate prodrugs
|
|
US8703177B2
(en)
|
2011-08-18 |
2014-04-22 |
Biodelivery Sciences International, Inc. |
Abuse-resistant mucoadhesive devices for delivery of buprenorphine
|
|
EP2750767A4
(en)
|
2011-09-02 |
2015-10-14 |
Univ Columbia |
INHIBITORS OF CAMKII, IP3R, CALCINEURIN, P38 AND MK2 / 3 TO TREAT METABOLIC DISTURBANCES OF OBESITY
|
|
CN104203936B
(zh)
|
2011-12-11 |
2017-04-19 |
威尔金制药有限公司 |
金属酶抑制剂化合物
|
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
|
ES2774267T3
(es)
|
2012-01-20 |
2020-07-20 |
Mycovia Pharmaceuticals Inc |
Compuestos inhibidores de metaloenzimas
|
|
US8877967B2
(en)
|
2012-03-23 |
2014-11-04 |
Oxigene, Inc. |
Compositions and methods for inhibition of cathepsins
|
|
PT2830662T
(pt)
|
2012-03-29 |
2018-11-29 |
Univ Columbia |
Métodos para tratamento de distúrbios de perda de pelo
|
|
WO2013173506A2
(en)
|
2012-05-16 |
2013-11-21 |
Rigel Pharmaceuticals, Inc. |
Method of treating muscular degradation
|
|
US20140213555A1
(en)
|
2013-01-25 |
2014-07-31 |
Rigel Pharmaceuticals, Inc. |
Compounds and method for treating autoimmune diseases
|
|
EP2968551B1
(en)
|
2013-03-15 |
2021-05-05 |
The Trustees of Columbia University in the City of New York |
Fusion proteins and methods thereof
|
|
US20150157509A1
(en)
*
|
2013-12-11 |
2015-06-11 |
Oscar Polk Atkinson |
Occlusive skin covering
|
|
US20150174386A1
(en)
*
|
2013-12-19 |
2015-06-25 |
Kimberly-Clark Worldwide, Inc. |
Transdermal device containing microneedles
|
|
MX2016011517A
(es)
|
2014-03-07 |
2017-04-13 |
Univ Arizona |
Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.
|
|
JP2017514790A
(ja)
|
2014-03-19 |
2017-06-08 |
ヴィアメット ファーマスーティカルズ，インコーポレイテッド |
抗真菌化合物の調製方法
|
|
EP3778644A3
(en)
|
2014-12-23 |
2021-06-02 |
The Trustees of Columbia University in the City of New York |
Fgfr-tacc fusion proteins and methods thereof
|
|
SI3271347T1
(sl)
|
2015-03-19 |
2022-11-30 |
Mycovia Pharmaceuticals, Inc. |
Protiglivične spojine in postopki za izdelavo
|
|
US10065946B2
(en)
|
2015-08-04 |
2018-09-04 |
Rigel Pharmaceuticals, Inc. |
Benzazole compounds and methods for making and using the compounds
|
|
CA2998808A1
(en)
|
2015-09-18 |
2017-03-23 |
Vps-3, Inc. |
Polymorphs of an antifungal tetrazolyl pyridine compound
|
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
|
JP6803923B2
(ja)
|
2015-12-30 |
2020-12-23 |
エヌキューピー １５９８，リミテッド |
金属酵素阻害化合物
|
|
JP6960937B2
(ja)
|
2016-03-08 |
2021-11-05 |
リビング プルーフ インコーポレイテッド |
長期持続性化粧品組成物
|
|
EP3475263B1
(en)
|
2016-06-27 |
2022-12-28 |
Rigel Pharmaceuticals, Inc. |
2,4-diamino-pyrimidine compounds and their use as irak4 inhibitors
|
|
EP3478091B1
(en)
|
2016-06-29 |
2024-03-20 |
Halo Life Science, LLC |
Method of preparing a low odor dicholinium ellagate salt and other low odor organic salts of choline
|
|
CN110234637B
(zh)
|
2016-10-26 |
2022-11-01 |
里格尔药品股份有限公司 |
用作irak抑制剂的吡唑酰胺化合物
|
|
ES2939232T3
(es)
|
2016-10-26 |
2023-04-20 |
Rigel Pharmaceuticals Inc |
Derivados de oxazol para uso como inhibidores de IRAK y método para su preparación
|
|
EP3562306A4
(en)
|
2016-12-29 |
2020-06-24 |
Selenity Therapeutics (Bermuda), Ltd. |
METALLOENZYME INHIBITOR COMPOUNDS
|
|
AU2017387033B2
(en)
|
2016-12-29 |
2024-02-01 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
GB201708579D0
(en)
*
|
2017-05-30 |
2017-07-12 |
Univ Of Wolverhampton Science Park Ltd |
Wound dressing
|
|
JP7167069B2
(ja)
|
2017-06-29 |
2022-11-08 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
キナーゼ阻害剤ならびに作製および使用のための方法
|
|
GB2561262B
(en)
*
|
2017-07-13 |
2019-03-20 |
Dentmed Ltd |
A targeted drug delivery pad
|
|
EP3681921A2
(en)
|
2017-09-13 |
2020-07-22 |
Living Proof, Inc. |
Color protectant compositions
|
|
JP7244495B2
(ja)
|
2017-09-13 |
2023-03-22 |
リビング プルーフ インコーポレイテッド |
長期持続性の化粧品組成物
|
|
US20210292410A1
(en)
|
2017-12-07 |
2021-09-23 |
Morphosys Ag |
Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
|
|
PT3788044T
(pt)
|
2018-05-03 |
2023-08-31 |
Rigel Pharmaceuticals Inc |
Compostos inibidores de rip1 e métodos para preparar e usar os mesmos
|
|
HRP20230909T1
(hr)
|
2018-05-03 |
2023-12-08 |
Rigel Pharmaceuticals, Inc. |
Spojevi inhibitori rip1 i postupci za njihovo dobivanje i upotrebu
|
|
US20220000880A1
(en)
|
2018-11-01 |
2022-01-06 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
|
US11090346B2
(en)
|
2019-05-28 |
2021-08-17 |
Inbold Inc. |
Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery
|
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
|
BR112022001418A2
(pt)
|
2019-08-08 |
2022-06-07 |
Rigel Pharmaceuticals Inc |
Compostos e método para tratar a síndrome de liberação de citocinas
|
|
WO2021030526A1
(en)
|
2019-08-14 |
2021-02-18 |
Rigel Pharmaceuticals, Inc. |
Method of blocking or ameliorating cytokine release syndrome
|
|
PE20220970A1
(es)
|
2019-08-30 |
2022-06-10 |
Rigel Pharmaceuticals Inc |
Compuestos de pirazol, formulaciones de los mismos y un metodo para usar los compuestos y/o formulaciones
|
|
EP4025575A1
(en)
|
2019-09-06 |
2022-07-13 |
Rigel Pharmaceuticals, Inc. |
Rip1 inhibitory compounds and methods for making and using the same
|
|
JP7376218B2
(ja)
|
2019-09-06 |
2023-11-08 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Ｒｉｐ１阻害化合物ならびにそれを作製および使用するための方法
|
|
TW202132307A
(zh)
|
2019-11-07 |
2021-09-01 |
美商雷傑製藥公司 |
雜環ｒｉｐ１抑制性化合物
|
|
US20220288047A1
(en)
|
2021-03-03 |
2022-09-15 |
Rigel Pharmaceuticals, Inc. |
Method for treating a disease or condition using a pyrazole compound or formulation thereof
|
|
AR125587A1
(es)
|
2021-03-11 |
2023-08-02 |
Rigel Pharmaceuticals Inc |
Inhibidores heterocíclicos de la quinasa de rip1
|
|
WO2023136749A1
(ru)
*
|
2022-01-11 |
2023-07-20 |
Павел Владимирович КОРЧАГИН |
Система и способ обеспечения безопасности для держателей банковских карт
|
|
WO2023183377A1
(en)
|
2022-03-23 |
2023-09-28 |
Rigel Pharmaceuticals, Inc. |
Pyrimid-2-yl-pyrazole compounds as irak inhibitors
|
|
US20230312568A1
(en)
|
2022-03-31 |
2023-10-05 |
Rigel Pharmaceuticals, Inc. |
Tricyclic irak inhibitors
|
